Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | DNMT3A |
Variant | E30A |
Impact List | missense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | DNMT3A E30A does not lie within any known functional domains of the Dnmt3a protein (UniProt.org). E30A does not lead to Dnmt3a instability but results in decreased methyltransferase activity in cell culture (PMID: 34429321), and therefore, is predicted to lead to a loss of Dnmt3a protein function. |
Associated Drug Resistance | |
Category Variants Paths |
DNMT3A mutant DNMT3A inact mut DNMT3A E30A |
Transcript | NM_022552.5 |
gDNA | chr2:g.25300227T>G |
cDNA | c.89A>C |
Protein | p.E30A |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_022552 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
XM_017003526.2 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
XM_047443593.1 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
NM_175629 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
XM_005264175.5 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
XM_005264175 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
XM_011532664 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
NM_001320892.1 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
XM_017003526 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
XM_017003526.1 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
NM_175630.1 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
XM_011532664.3 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
NM_022552.4 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
NM_175629.2 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
NM_175630.1 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
NM_022552.5 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
XM_005264175.6 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
NM_001320892 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
NM_001320892.2 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
NM_175630 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
NM_175629.2 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
XM_011532664.2 | chr2:g.25300227T>G | c.89A>C | p.E30A | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|